The Department of Defense, specifically the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement to provide reagents and equipment compatible with Hologic’s SARS CoV-2 & Flu A/B reagents for the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement aims to secure a fully automated molecular analyzer capable of processing a high volume of samples efficiently, along with necessary reagents and services to support nucleic acid amplification testing (NAAT) for various bacterial and fungal infections, including Bacterial Vaginosis and Chlamydia trachomatis. This initiative is part of broader public health strategies to enhance disease detection and management, particularly in women's health. Interested vendors should respond with their capabilities and relevant information by contacting Medina L. Woodson at medina.l.woodson.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil, with the base period of performance expected from June 1, 2025, to September 30, 2025.